BIOM-43. CROSS-PLATFORM ROBUSTNESS IN THE GLUCOCORTICOID RESPONSE PHARMACODYNAMIC BIOMARKER. (12th November 2021)

• Record Type: Journal Article
• Authors: Tang, Emily; Wiencke, John; Warrier, Gayathri; Hansen, Helen; McCoy, Lucie; Rice, Terri; Bracci, Paige; Wrensch, Margaret; Taylor, Jennie; Clarke, Jennifer; Koestler, Devin; Salas, Lucas; Christensen, Brock; Kelsey, Karl; Molinaro, Annette
• Is Part Of: Neuro-oncology. Volume 23: Supplement 6(2021)
• Page Start: vi20
• Page End: vi20
• Publication Date: 2021-11-12
• Subjects: Brain Neoplasms -- Periodicals; Brain -- Tumors -- Periodicals; Brain -- Cancer -- Periodicals; Nervous system -- Cancer -- Periodicals; 616.99481
• DOI: 10.1093/neuonc/noab196.074
• Languages: English
• ISSNs: 1522-8517

Abstract

Abstract: The neutrophil dexamethasone methylation index (NDMI) is an algorithm-based biomarker to assess individuals' exposures to dexamethasone, a synthetic glucocorticoid commonly administered for inflammation. Cortisol is the main endogenous glucocorticoid that controls vital processes including the immune response and lipid and carbohydrate metabolism. Variations in the NDMI score reflect individuals' sensitivities of exposures to both exogenous and endogenous glucocorticoids, and this biomarker was trained using elastic net regression on Illumina's most recent DNA methylation beadarray, the EPIC array, which contains 850, 000 cytosine-guanine (CpG) sites. While technology for microarray research continues to advance over time, researchers are capable of conducting more comprehensive epigenome-wide association studies (EWAS). However, many studies are still run and archived using Illumina's historical 450K platform with approximately 450, 000 CpGs, and there are fewer published databases using the 850K EPIC array. To evaluate the cross-platform bioinformatic comparability, we performed elastic net regression modeling using predictors available in the 450K to train the NDMI. Among the 135 pre-surgery glioma cases from the UCSF Immune Profiles Study (IPS), NDMI scores between the 450K and 850K model were strongly correlated (r = 0.99, p < 0.0001). In the 311 controls from the UCSF Adult Glioma Study (AGS), similar correlations were observed (r = 0.96, p < 0.0001). We observe that NDMI remains a robust tool using historical 450K data and conclude that this algorithmic tool is capable of detecting the variations in individuals' responses to dexamethasone.